In the context of breast cancer, our results revealed that BMPs reduce β-CATENIN protein stability through direct involvement of SMAD4 in MCF7 and T47D cells; in turn, SMAD4 affects the nuclear accumulation and target gene expression of β-CATENIN in MCF7 cells. The gene discussed is CLN5; the disease is breast carcinoma.